American Gene™

A cell & #genetherapy company with a #gene delivery platform to develop cures to #cancer #HIV #PKU. In Phase 1 trial for #HIVcure. CEO @JeffreyGalvin.

[American Gene™ @americangene]

We've completed two clinical trials on our HIV CURE PROJECT with promising data. Now we need your help to try to take it to the finish line. Please consider donating today or sharing with someone who could.
https://t.co/KeQZZtJUFF
#HIVCure #HIV #Donate

[American Gene™ @americangene]

Tune in to Cell & Gene: The Podcast and hear Addimmune's Dr. Marcus Conant, a pioneer in HIV research, discuss our innovative cell therapy for HIV. He shares his vision for empowering patients and transforming HIV treatment.
https://t.co/DbdhIx93pP
#HIV #celltherapy #biotech

[American Gene™ @americangene]

M&A has been steady in 2024. We count 47 private & public deals to date totaling $53 billion. 15 have been >$1 billion with cancer, rare disease & cell therapies some of the areas of interest.

[American Gene™ @americangene]

AGT CEO, Jeff Galvin, had a chat with HIV advocate, Raif Derrazi, to discuss the latest updates on our AGT103-T clinical trials. Discover what lies ahead in our mission to find a cure for HIV!
https://t.co/jg56f87l1j
#HIVResearch #ClinicalTrials

[American Gene™ @americangene]

Can genetic evidence make drugs more effective? A new study in Nature suggests YES. Drug mechanisms with genetic support have a 2.6x higher chance of success. https://t.co/50LvaHVyty
#genetics #science #healthcare

[American Gene™ @americangene]

Dr. Marcus Conant will be participating in a roundtable on cell and #GeneTherapy alongside Andrew Dietz, MD, of @ShapeTX at this year’s CMO Summit 360 on April 18 at 12:50 PM ET. Learn more: https://t.co/kqHJgIhF9N #CMO360

[American Gene™ @americangene]

The future of medicine! The strategic market insight company Nova 1 values the cell & gene therapy market @ $18 billion in 2023 growing at a CAGR of 18% over the next decade. They see a near $100 billion market size by 2033.
https://t.co/Sml8CE8R61
#genetherapy #futureofmedicine

[American Gene™ @americangene]

This #NYHAAD, we support @NYHAAD and their mission to create meaningful and intentional spaces for young people to ask questions, learn, and talk about the impacts of HIV and their community. #StopHIVTogether #EndHIVStigma

[American Gene™ @americangene]

Listen in with Dr. Marcus Conant as he discusses #genetherapy for HIV suppression with CGTLive here https://t.co/IBAW4Nqfcg

[American Gene™ @americangene]

We are grateful to have Dr. Marcus Conant represent our mission to find a functional cure for #HIV, especially at #CROI2024. Learn about his journey in @PharmaVoice: https://t.co/Rb4s6NWSoU

[American Gene™ @americangene]

More signs of continued momentum in the biotech industry!
Green shoots in IPO land with @boundlessbio following last month's @Kyverna_Tx & @altoneuro's debut on the exchanges. ecDNA oncology company will launch $100 million IPO.
https://t.co/j3zGeDxhmk
$BOLD $KYTX $ANRO

[American Gene™ @americangene]

🚨 TONIGHT! - Mar 27th, 4PM EST🚨 Catch AGT's CEO, Jeff Galvin, on DC News Now's "Moco Minute." He'll discuss HIV research from AGT and its HIV division, Addimmune, the future of the biotech industry and pushing innovation. https://t.co/2pehBMpZcZ
#AGT #Addimmune #MocoMinute

[American Gene™ @americangene]

R&D at the biggest biopharmaceuticals has increased quite a bit in 2023. Oncology, neuroscience and cardiovascular are some of the biggest areas where @astrazeneca, @Johnson&johnson, @novartis, @roche and @merck are spending.
https://t.co/xRaoD2ofJY

[American Gene™ @americangene]

The FDA approved @orchard_tx Lenmeldy for early juvenile metachromatic leukodystrophy! No treatment previously existed for this rare childhood genetic disease that leads to loss of motor & cognitive skill & eventually death.
https://t.co/Tu1D5BIqke
https://t.co/4TvWeTiDw3

[American Gene™ @americangene]

Despite weak investment in 2023, new drug approvals reached a high with approvals in five gene therapies, weight loss & Alzheimer's. https://t.co/rPDnlKgafK

[American Gene™ @americangene]

#ICYMI, our Chief Science Officer, Jeff Boyle, PhD, was featured in the 2024 March issue of Pharm Tech, providing commentary and insight on the development of Gamma-Delta T-cell therapies – and how we are leveraging #GeneTherapy. Read more: https://t.co/eWmXhQKVT4

[American Gene™ @americangene]

On this National Native HIV and AIDS Awareness Day (#NNHAAD), we're rallying behind a national movement to empower Native communities across the US and its territories to learn about the disease, get tested, join prevention efforts, and seek care for #HIV.

[American Gene™ @americangene]

@Mustang_Bio achieves CAR-T success with recurrent brain cancer. 70% improvement in survival as reported in Nature, The science is advancing! Fierce Biotech article: https://t.co/nQNDZr7J4Y
#science #biotech #success
RT to help spread awareness of this amazing CAR-T progress!

[American Gene™ @americangene]

Public biotechs have raked in $10 billion this year, and the XBI is up over 50%! Gene therapy leaders are driving the momentum. https://t.co/KSgcCTIi2Q
#FOMO #biotech #investing
Are you seeing this trend too? Let us know with a 👍

[American Gene™ @americangene]

Today is National Women and Girls HIV/AIDS Awareness Day. The National HIV/AIDS Strategy provides a national strategy to accelerate efforts to end the #HIV epidemic by 2030. Click here to read a summary: https://t.co/2uFlLjjdXf #NWGHAAD